DEA Proposes Massive Increase In Marijuana And Psilocybin Production For Research To Develop FDA-Approved Medicine Published 6 days ago on September 1, 2021By Kyle Jaeger https://www.marijuanamoment.net/dea-proposes-massive-increase-in-marijuana-and-psilocybin-production-for-research-to-develop-fda-approved-medicines/ "The Drug Enforcement Administration (DEA) is proposing a massive increase in the production of marijuana and psilocybin for research purposes, with the intent of aiding in the development of new federally approved therapeutic medications. When it comes to psilocybin and psilocin—the key psychoactive components of so-called magic mushrooms—DEA massively increased its production goals"
"At first, the quota was set at 50 grams for psilocybin. Now it’s been revised to 1,500 grams—a 2,900 percent increase. DEA also wants to manufacture 1,000 grams of psilocin, instead of just 50 grams as initially proposed." "This is welcome news for researchers and advocates. It shows a willingness from the leading federal drug enforcement agency to recognize an emerging scientific field and promote studies into the substances regardless of their Schedule I status."
"Canada is embracing psilocybin as medicine for four terminally ill patients. Many new studies are exploring the medical properties of the substance, and finding that it’s helpful in treating conditions like depression."
Proposed Adjustments to the Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2021
